1
|
Wurm J, Uka A, Bernet V, Buettcher M, Giannoni E, Kottanattu L, Schöbi N, Zemmouri A, Ritz N, Zimmermann P. The changing clinical presentation of COVID-19 in children during the course of the pandemic. Acta Paediatr 2024; 113:771-777. [PMID: 38102898 DOI: 10.1111/apa.17061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 10/21/2023] [Accepted: 12/06/2023] [Indexed: 12/17/2023]
Abstract
AIM To investigate the evolution of clinical symptoms of COVID-19 in children throughout the pandemic. METHODS In this national prospective surveillance study, symptoms in children hospitalised with COVID-19 were collected from all paediatric hospitals in Switzerland between March 2020 and March 2023. Data was analysed across four time periods, according to the predominantly circulating SARS-CoV-2 variant: T1 (wild-type), T2 (Alpha), T3 (Delta) and T4 (Omicron), as well as by age group. RESULTS The study included 1323 children. The proportion of children admitted to an intensive care unit remained stable throughout the pandemic. However, the pattern and frequency of clinical manifestations changed over time. Respiratory symptoms were less prevalent during T1 (wild-type), fever during T2 (Alpha) and rash during T4 (Omicron). In contrast, fever and neurological symptoms were more prevalent during T4 (Omicron). Newly described symptoms during T4 (Omicron) included conjunctivitis, laryngotracheitis and seizures. Fever was more prevalent among neonates and infants whereas respiratory symptoms were more common among infants. Gastrointestinal symptoms were more frequent among toddlers, while both toddlers and school-aged children presented with neurological symptoms more often than other age groups. CONCLUSION Continuous surveillance is required to detect changes in manifestations and there by be prepared for the optimal management of complications in children with COVID-19.
Collapse
Affiliation(s)
- Juliane Wurm
- Department of Paediatrics, Fribourg Hospital, Fribourg, Switzerland
- Department of Health Science and Medicine, University Lucerne, Lucerne, Switzerland
| | - Anita Uka
- Department Women-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland
| | - Vera Bernet
- Department of Neonatology, Hospital Zollikerberg, Zollikerberg, Switzerland
| | - Michael Buettcher
- Infectious Diseases Unit, Children's Hospital Lucerne, Lucerne, Switzerland
- Faculty of Health Science and Medicine, University Lucerne, Lucerne, Switzerland
- Paediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel, Basel, Switzerland
| | - Eric Giannoni
- Clinic of Neonatology, Department Mother-Woman-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - Lisa Kottanattu
- Pediatric Institute of Southern Switzerland, Ente Ospedaliero Cantonale, EOC, Bellinzona, Switzerland
- Faculty of Biomedical Sciences, Università della Svizzera Italiana, USI, Lugano, Switzerland
| | - Nina Schöbi
- Department of Pediatrics, Division of Pediatric Infectious Diseases, Inselspital, Bern University Hospital, University of Berne, Berne, Switzerland
| | | | - Nicole Ritz
- Department of Health Science and Medicine, University Lucerne, Lucerne, Switzerland
- Mycobacterial and Migrant Health Research, University Children's Hospital Basel and Department for Clinical Research, University of Basel, Basel, Switzerland
- Department of Paediatrics, The University of Melbourne, Parkville, Australia
| | - Petra Zimmermann
- Department of Paediatrics, Fribourg Hospital, Fribourg, Switzerland
- Department of Paediatrics, The University of Melbourne, Parkville, Australia
- Infectious Diseases Research Group, Murdoch Children's Research Institute, Parkville, Australia
- Department of Community Health, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
| |
Collapse
|
3
|
Yakoubi M, Meziani N, Yahia Cherif M, Zemmouri A, Benbakouche R. Fracture pathologique du scaphoïde carpien (kyste synovial intraosseux). Aspect clinique et thérapeutique. À propos d’un cas. ACTA ACUST UNITED AC 2009; 28:37-41. [DOI: 10.1016/j.main.2008.11.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2008] [Revised: 08/17/2008] [Accepted: 11/03/2008] [Indexed: 11/27/2022]
|
4
|
Zemmouri A, Kouachi T, Bellas M, Zoubir S, Omari A, Chergut A, Berrah M. La dysplasie broncho-pulmonaire dans un pays en developpement. Arch Pediatr 1999. [DOI: 10.1016/s0929-693x(99)81767-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|